St. Luke’s Hospital Selects Micromedex Information Solutions from Thomson Reuters for Clinical Decision Support

Ann Arbor, MI .— St. Luke’s Hospital has signed an agreement to extend its use of Micromedex® healthcare solutions from Thomson Reuters as its key resource for clinical information.

St. Luke’s, a 493-bed, not-for-profit hospital in Chesterfield, Missouri, already makes extensive use of the Micromedex Healthcare Series for drug, toxicology, disease, alternative medicine, and patient education information. Under the new agreement, St. Luke’s will add clinical decision support tools from Micromedex to its physician portal and medication reconciliation tools.

“We conducted a comprehensive analysis of five vendors in this market, evaluating their products on clinical data, technology, and pricing. We found that Micromedex was the best value proposition for St. Luke’s,” said Scott Holtswarth, the hospital’s Director of Information Services. “From a technical perspective, a key differentiator was the ability of Micromedex to integrate its products with our current technology infrastructure. This includes our Intranet, bedside medication administration system, and a physician portal we developed in-house.”

“From a clinical perspective, Micromedex is a very timely and comprehensive resource, which is what clinicians need to make the best clinical decisions possible,” said Richard Fook, St. Luke’s Hospital Director of Pharmacy. “It’s also an excellent reference for patient education and medical education. Clinically, Micromedex offered the most comprehensive drug information database in a user-friendly format that will enhance our clinical decision support efforts.”